Kin Ho Chan

1.0k citations
5 papers · 588 indexed · 1 hit paper · h-index 5

Kin Ho Chan

5 papers receiving 579 citations

Hit Papers

Neutralizing antibody titres in SARS-CoV-2 infections209202120262022202450100150200

Peers

Kin Ho Chan
Comparison fields: 5 of 65
  • Infectious Diseases 535
  • Modeling and Simulation 39
  • Animal Science and Zoology 78
  • Health 34
  • Neurology 46
Replace Vivian Chih-Wei Chen with:
Vivian Chih-Wei Chen Singapore
Asmaa Hachim Hong Kong
Ronald LW Ko Hong Kong
Christina Capuano United States
Olha Puhach Switzerland
Disha Bhavsar United States
Wai Hung Chan Hong Kong
Zoë L. Lyski United States
Kenji Nishiura United States
Zhong‐Tao Xin China
Kin Ho Chan relative to Vivian Chih-Wei Chen Singapore Vivian Chih-Wei Chen's profile →
Citations per field
00.5×1.5×2.1×
Vivian Chih-Wei Chen · 1×
Citations per year

Countries citing papers authored by Kin Ho Chan

Since Specialization
Citations

This map shows the geographic impact of Kin Ho Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kin Ho Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kin Ho Chan more than expected).

Fields of papers citing papers by Kin Ho Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kin Ho Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kin Ho Chan. The network helps show where Kin Ho Chan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kin Ho Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kin Ho Chan Line = papers co-authored together Kin Ho Chan links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1 20235
2
Neutralizing antibody titres in SARS-CoV-2 infectionsbreakdown →
2021209
3 2020102
4 2020232
5 201340

About Kin Ho Chan

Kin Ho Chan is a scholar working on Infectious Diseases, Microbiology and Complementary and alternative medicine, having authored 5 papers that have together received 588 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), SARS-CoV-2 detection and testing (3 papers), COVID-19 Clinical Research Studies (2 papers), Inflammatory mediators and NSAID effects (1 paper), Antimicrobial Peptides and Activities (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Medicinal plant effects and applications (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Infectious Diseases (535 citations), Modeling and Simulation (39 citations) and Animal Science and Zoology (78 citations). Kin Ho Chan has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Ranawaka A. P. M. Perera, Malik Peiris, Leo L. M. Poon, Ronald LW Ko, David S.C. Hui, Owen TY Tsang, Samuel M. S. Cheng, Mike Yat Wah Kwan, Joseph T. Wu and Kathy Leung. Their work appears in journals such as Nature Communications, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026